Evolution-guided phage therapy for antimicrobial-resistant Acinetobacter baumannii: from resistance evolution and genomic plasticity to receptor-associated fitness trade-offs and clinical translation

Chuhan Wang, Guoliang Zhang, Honglan Huang

Open source

DOI
10.3389/fmicb.2026.1910892
Published
2026-10-19
Container
Frontiers in Microbiology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmicb.2026.1910892,
  title = {Evolution-guided phage therapy for antimicrobial-resistant Acinetobacter baumannii: from resistance evolution and genomic plasticity to receptor-associated fitness trade-offs and clinical translation},
  author = {Chuhan Wang and Guoliang Zhang and Honglan Huang},
  year = {2026},
  journal = {Frontiers in Microbiology},
  doi = {10.3389/fmicb.2026.1910892},
  url = {https://doi.org/10.3389/fmicb.2026.1910892}
}

RIS

TY  - JOUR
TI  - Evolution-guided phage therapy for antimicrobial-resistant Acinetobacter baumannii: from resistance evolution and genomic plasticity to receptor-associated fitness trade-offs and clinical translation
AU  - Chuhan Wang
AU  - Guoliang Zhang
AU  - Honglan Huang
PY  - 2026
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1910892
UR  - https://doi.org/10.3389/fmicb.2026.1910892
ER  - 

APA

Wang, C., Zhang, G., & Huang, H. (2026). Evolution-guided phage therapy for antimicrobial-resistant Acinetobacter baumannii: from resistance evolution and genomic plasticity to receptor-associated fitness trade-offs and clinical translation. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2026.1910892

Source records